Cytotoxic and antitumor antibiotics produced by microorganisms.
D015250:Aclarubicin; D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic / Q000096:biosynthesis* / Q000266:history; D001419:Bacteria / Q000378:metabolism*; D001570:Benzodiazepinones / Q000096:biosynthesis; D001761:Bleomycin / Q000096:biosynthesis; D002621:Chemistry; D004317:Doxorubicin / Q000031:analogs & derivatives / Q000096:biosynthesis; D005658:Fungi / Q000378:metabolism*; D049673:History, 20th Century; D007564:Japan; D008453:Maytansine / Q000031:analogs & derivatives / Q000096:biosynthesis; D009279:Naphthacenes / Q000096:biosynthesis; D017663:Peplomycin; D010452:Peptide Biosynthesis; D010455:Peptides; D013329:Structure-Activity Relationship
D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D001570:Benzodiazepinones; D009279:Naphthacenes; D010455:Peptides; C001666:auromomycin; D001761:Bleomycin; D008453:Maytansine; D017663:Peplomycin; C013354:sporamycin; C012453:neothramycins; C015682:ansamitocins; D015250:Aclarubicin; D004317:Doxorubicin; C027260:pirarubicin